Mechanisms regulating the development and function of natural regulatory T cells

Archivum Immunologiae et Therapiae Experimentalis

Volumn 56, Issue 2, 2008, Pages 85-102

  Gupta, Sonal ^a   Shang, Weirong ^b   Sun, Zuoming ^a,c  

^a UNIVERSITY OF ILLINOIS   (United States)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

Author keywords

Development; PKC ; Signaling; T cell activation; Treg

Indexed keywords

AUTOANTIGEN; PROTEIN KINASE C THETA;

ALLERGY; AUTOIMMUNITY; HOMEOSTASIS; HUMAN; IMMUNOLOGICAL TOLERANCE; LYMPHOCYTE FUNCTION; LYMPHOCYTE PROLIFERATION; MICROBIAL IMMUNITY; ORGAN TRANSPLANTATION; REGULATORY T LYMPHOCYTE; REVIEW; SIGNAL TRANSDUCTION; THYMOCYTE; TUMOR IMMUNITY;

ANIMALS; CELL COMMUNICATION; CYTOKINES; FORKHEAD TRANSCRIPTION FACTORS; HUMANS; IMMUNE TOLERANCE; LYMPHOCYTE ACTIVATION; RECEPTORS, ANTIGEN, T-CELL; SIGNAL TRANSDUCTION; T-LYMPHOCYTES, REGULATORY;

EID: 42349114769     PISSN: 0004069X     EISSN: 16614917     Source Type: Journal    
DOI: 10.1007/s00005-008-0015-4     Document Type: Review

References (181)

1. Akiyama T., Maeda S., Yamane S., Ogino K., Kasai M., Kajiura F., Matsumoto M. and Inoue J. (2005): Dependence of self-tolerance on TRAF6-directed development of thymic stroma. Science, 308, 248-251.
2. Almeida A. R., Legrand N., Papiernik M. and Freitas A. A. (2002): Homeostasis of peripheral CD4+ T cells: IL-2R alpha and IL-2 shape a population of regulatory cells that controls CD4+ T cell numbers. J. Immunol., 169, 4850-4860.
3. Anderson K., Fitzgerald M., Dupont M., Wang T., Paz N., Dorsch M., Healy A., Xu Y., Ocain T., Schopf L., Jaffee B. and Picarella D. (2006): Mice deficient in PKC theta demonstrate impaired in vivo T cell activation and protection from T cell-mediated inflammatory diseases. Autoimmunity, 39, 469-478.
4. Anderson M. S., Venanzi E. S., Chen Z., Berzins S. P., Benoist C. and Mathis D. (2005): The cellular mechanism of Aire control of T cell tolerance. Immunity, 23, 227-239.
5. Anderson M. S., Venanzi E. S., Klein L., Chen Z., Berzins S. P., Turley S. J., von Boehmer H., Bronson R., Dierich A., Benoist C. and Mathis D. (2002): Projection of an immunological self shadow within the thymus by the aire protein. Science, 298, 1395-1401.
6. Annacker O., Pimenta-Araujo R., Burlen-Defranoux O., Barbosa T. C., Cumano A. and Bandeira A. (2001): CD25+ CD4+ T cells regulate the expansion of peripheral CD4 T cells through the production of IL-10. J. Immunol., 166, 3008-3018.
7. Annunziato F., Cosmi L., Liotta F., Lazzeri E., Manetti R., Vanini V., Romagnani P., Maggi E. and Romagnani S. (2002): Phenotype, localization, and mechanism of suppression of CD4(+)CD25(+) human thymocytes. J. Exp. Med., 196, 379-387.
8. Antov A., Yang L., Vig M., Baltimore D. and Van Parijs L. (2003): Essential role for STAT5 signaling in CD25+CD4+ regulatory T cell homeostasis and the maintenance of self-tolerance. J. Immunol., 171, 3435-3441.
9. Apostolou I., Sarukhan A., Klein L. and von Boehmer H. (2002): Origin of regulatory T cells with known specificity for antigen. Nat. Immunol., 3, 756-763.
10. Asano M., Toda M., Sakaguchi N. and Sakaguchi S. (1996): Autoimmune disease as a consequence of developmental abnormality of a T cell subpopulation. J. Exp. Med., 184, 387-396.
11. Aschenbrenner K., D'Cruz L. M., Vollmann E. H. Hinterberger M., Emmerich J., Swee L. K., Rolink A. and Klein L. (2007): Selection of Foxp3+ regulatory T cells specific for self antigen expressed and presented by Aire+ medullary thymic epithelial cells. Nat. Immunol., 8, 351-358.
12. Asseman C., Mauze S., Leach M. W., Coffman R. L. and Powrie F. (1999): An essential role for interleukin 10 in the function of regulatory T cells that inhibit intestinal inflammation. J. Exp. Med., 190, 995-1004.
13. Asseman C., Read S. and Powrie F. (2003): Colitogenic Th1 cells are present in the antigen-experienced T cell pool in normal mice: control by CD4+ regulatory T cells and IL-10. J. Immunol., 171, 971-978.
14. Azuma T., Takahashi T., Kunisato A., Kitamura T. and Hirai H. (2003): Human CD4+ CD25+ regulatory T cells suppress NKT cell functions. Cancer Res., 63, 4516-4520.
15. Baecher-Allan C., Brown J. A., Freeman G. J. and Hafler D. A. (2001): CD4+CD25high regulatory cells in human peripheral blood. J. Immunol., 167, 1245-1253.
16. Baecher-Allan C., Viglietta V. and Hafler D. A. (2004): Human CD4+CD25+ regulatory T cells. Semin. Immunol., 16, 89-98.
17. Balandina A., Lecart S., Dartevelle P., Saoudi A. and Berrih-Aknin S. (2005): Functional defect of regulatory CD4(+)CD25+ T cells in the thymus of patients with autoimmune myasthenia gravis. Blood, 105, 735-741.
18. Banz, A., Pontoux C. and Papiernik M. (2002): Modulation of Fas-dependent apoptosis: a dynamic process controlling both the persistence and death of CD4 regulatory T cells and effector T cells. J. Immunol., 169, 750-757.
19. Bennett C. L., Christie J., Ramsdell F., Brunkow M. E., Ferguson P. J., Whitesell L., Kelly T. E., Saulsbury F. T., Chance P. F. and Ochs H. D. (2001): The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3. Nat. Genet., 27, 20-21.
20. Bettelli E., Dastrange M. and Oukka M. (2005): Foxp3 interacts with nuclear factor of activated T cells and NF-kappa B to repress cytokine gene expression and effector functions of T helper cells. Proc. Natl. Acad. Sci. USA, 102, 5138-5143.
21. Boitard C., Yasunami R., Dardenne M. and Bach J. F. (1989): T cell-mediated inhibition of the transfer of autoimmune diabetes in NOD mice. J. Exp. Med., 169, 1669-1680.
22. Bruder D., Probst-Kepper M., Westendorf A. M., Geffers R., Beissert S., Loser K., von Boehmer H., Buer J. and Hansen W. (2004): Neuropilin-1: a surface marker of regulatory T cells. Eur. J. Immunol., 34, 623-630.
23. Brunkow M. E., Jeffery E. W., Hjerrild K. A., Paeper B., Clark L. B., Yasayko S. A., Wilkinson J. E., Galas D., Ziegler S. F. and Ramsdell F. (2001): Disruption of a new forkhead/winged-helix protein, scurfin, results in the fatal lymphoproliferative disorder of the scurfy mouse. Nat. Genet., 27, 68-73.
24. Bystry R. S., Aluvihare V., Welch K. A., Kallikourdis M. and Betz A. G. (2001): B cells and professional APCs recruit regulatory T cells via CCL4. Nat. Immunol., 2, 1126-1132.
25. Cabarrocas J., Cassan C., Magnusson F., Piaggio E., Mars L., Derbinski J., Kyewski B., Gross D. A., Salomon B. L., Khazaie K., Saoudi A. and Liblau R. S. (2006): Foxp3+ CD25+ regulatory T cells specific for a neo-self-antigen develop at the double-positive thymic stage. Proc. Natl. Acad. Sci. USA, 103, 8453-8458.
26. Cao X., Cai S. F., Fehniger T. A., Song J., Collins L. I., Piwnica-Worms D. R. and Ley T. J. (2007): Granzyme B and perforin are important for regulatory T cell-mediated suppression of tumor clearance. Immunity, 27, 635-646.
27. Caramalho I., Lopes-Carvalho T., Ostler D., Zelenay S., Haury M. and Demengeot J. (2003): Regulatory T cells selectively express toll-like receptors and are activated by lipopolysaccharide. J. Exp. Med., 197, 403-411.
28. Carter J. D., Calabrese G. M., Naganuma M. and Lorenz U. (2005): Deficiency of the Src homology region 2 domain-containing phosphatase 1 (SHP-1) causes enrichment of CD4+CD25+ regulatory T cells. J. Immunol., 174, 6627-6638.
29. Caton A. J., Cozzo C., Larkin J. 3rd, Lerman M. A., Boesteanu A. and Jordan M. S. (2004): CD4(+) CD25(+) regulatory T cell selection. Ann. NY Acad. Sci., 1029, 101-114.
30. Cederbom, L., Hall H. and Ivars F. (2000): CD4+CD25+ regulatory T cells down-regulate co-stimulatory molecules on antigen-presenting cells. Eur. J. Immunol., 30, 1538-1543.
31. Chen W., Jin W., Hardegen N., Lei K. J., Li L., Marinos N., McGrady G. and Wahl S. M. (2003): Conversion of peripheral CD4+CD25- naive T cells to CD4+CD25+ regulatory T cells by TGF-beta induction of transcription factor Foxp3. J. Exp. Med., 198, 1875-1886.
32. Coudronniere N., Villalba M., Englund N. and Altman A. (2000): NF-kappa B activation induced by T cell receptor/CD28 costimulation is mediated by protein kinase C-theta. Proc. Natl. Acad. Sci. USA, 97, 3394-3399.
33. Cozzo C., Larkin J. 3rd and Caton A. J. (2003): Cutting edge: self-peptides drive the peripheral expansion of CD4+CD25+ regulatory T cells. J. Immunol., 171, 5678-5682.
34. D'Cruz L. M. and Klein L. (2005): Development and function of agonist-induced CD25+Foxp3+ regulatory T cells in the absence of interleukin 2 signaling. Nat. Immunol., 6, 1152-1159.
35. Derbinski J., Schulte A., Kyewski B. and Klein L. (2001): Promiscuous gene expression in medullary thymic epithelial cells mirrors the peripheral self. Nat. Immunol., 2, 1032-1039.
36. Dieckmann D., Plottner H., Berchtold S., Berger T. and Schuler G. (2001): Ex vivo isolation and characterization of CD4(+)CD25(+) T cells with regulatory properties from human blood. J. Exp. Med., 193, 1303-1310.
37. DiPaolo R. J., Glass D. D., Bijwaard K. E. and Shevach E. M. (2005): CD4+CD25+ T cells prevent the development of organ-specific autoimmune disease by inhibiting the differentiation of autoreactive effector T cells. J. Immunol., 175, 7135-7142.
38. Fallarino F., Grohmann U., Hwang K. W., Orabona C., Vacca C., Bianchi R., Belladonna M. L., Fioretti M. C., Alegre M. L. and Puccetti P. (2003): Modulation of tryptophan catabolism by regulatory T cells. Nat. Immunol., 4, 1206-1212.
39. Fallarino F., Grohmann U., You S., McGrath B. C., Cavener D. R., Vacca C., Orabona C., Bianchi R., Belladonna M. L., Volpi C., Santamaria P., Fioretti M. C. and Puccetti P. (2006): The combined effects of tryptophan starvation and tryptophan catabolites down-regulate T cell receptor zeta-chain and induce a regulatory phenotype in naive T cells. J. Immunol., 176, 6752-6761.
40. Fisson S., Darrasse-Jeze G., Litvinova E., Septier F., Klatzmann D., Liblau R. and Salomon B. L. (2003): Continuous activation of autoreactive CD4+ CD25+ regulatory T cells in the steady state. J. Exp. Med., 198, 737-746.
41. Fontenot J. D., Dooley J. L., Farr A. G. and Rudensky A. Y. (2005): Developmental regulation of Foxp3 expression during ontogeny. J. Exp. Med., 202, 901-906.
42. Fontenot J. D., Gavin M. A. and Rudensky A. Y. (2003): Foxp3 programs the development and function of CD4+CD25+ regulatory T cells. Nat. Immunol., 4, 330-336.
43. Fontenot J. D., Rasmussen J. P., Gavin M. A. and Rudensky A. Y. (2005): A function for interleukin 2 in Foxp3-expressing regulatory T cells. Nat. Immunol., 6, 1142-1151.
44. Fontenot J. D., Rasmussen J. P., Williams L. M., Dooley J. L., Farr A. G. and Rudensky A. Y. (2005): Regulatory T cell lineage specification by the forkhead transcription factor Foxp3. Immunity, 22, 329-341.
45. Fontenot J. D. and Rudensky A. Y. (2005): A well adapted regulatory contrivance: regulatory T cell development and the forkhead family transcription factor Foxp3. Nat. Immunol., 6, 331-337.
46. Fritzsching B., Oberle N., Eberhardt N., Quick S., Haas J., Wildemann B., Krammer P. H. and Suri-Payer E. (2005): In contrast to effector T cells, CD4+CD25+FoxP3+ regulatory T cells are highly susceptible to CD95 ligand- but not to TCR-mediated cell death. J. Immunol., 175, 32-36.
47. Gallegos A. M. and Bevan M. J. (2004): Central tolerance to tissue-specific antigens mediated by direct and indirect antigen presentation. J. Exp. Med., 200, 1039-1049.
48. Gavin M. A., Clarke S. R., Negrou E., Gallegos A. and Rudensky A. (2002): Homeostasis and anergy of CD4(+)CD25(+) suppressor T cells in vivo. Nat. Immunol., 3, 33-41.
49. Ge Q., Rao V. P., Cho B. K., Eisen H. N. and Chen J. (2001): Dependence of lymphopenia-induced T cell proliferation on the abundance of peptide/ MHC epitopes and strength of their interaction with T cell receptors. Proc. Natl. Acad. Sci. USA, 98, 1728-1733.
50. Gershon R. K., Cohen P., Hencin R. and Liebhaber S. A. (1972): Suppressor T cells. J. Immunol., 108, 586-590.
51. Gershon R. K. and Kondo K. (1970): Cell interactions in the induction of tolerance: the role of thymic lymphocytes. Immunology, 18, 723-737.
52. Ghiringhelli F., Menard C., Terme M., Flament C., Taieb J., Chaput N., Puig P. E., Novault S., Escudier B., Vivier E., Lecesne A., Robert C., Blay J. Y., Bernard J., Caillat-Zucman S., Freitas A., Tursz T., Wagner-Ballon O., Capron C., Vainchencker W., Martin F. and Zitvogel L. (2005): CD4+CD25+ regulatory T cells inhibit natural killer cell functions in a transforming growth factor-beta-dependent manner. J. Exp. Med., 202, 1075-1085.
53. Godfrey V. L., Wilkinson J. E. and Russell L. B. (1991): X-linked lymphoreticular disease in the scurfy (sf) mutant mouse. Am. J. Pathol., 138, 1379-1387.
54. Gondek D. C., Lu L. F., Quezada S. A., Sakaguchi S. and Noelle R. J. (2005): Cutting edge: contact-mediated suppression by CD4+CD25+ regulatory cells involves a granzyme B-dependent, perforin-independent mechanism. J. Immunol., 174, 1783-1786.
55. Grohmann U., Orabona C., Fallarino F., Vacca C., Calcinaro F., Falorni A., Candeloro P., Belladonna M. L., Bianchi R., Fioretti M. C. and Puccetti P. (2002): CTLA-4-Ig regulates tryptophan catabolism in vivo. Nat. Immunol., 3, 1097-1101.
56. Guiducci C., Valzasina B., Dislich H. and Colombo M. P. (2005): CD40/CD40L interaction regulates CD4+CD25+ T reg homeostasis through dendritic cell-produced IL-2. Eur. J. Immunol., 35, 557-567.
57. Harding F. A., McArthur J. G., Gross J. A., Raulet D. H. and Allison J. P. (1992): CD28-mediated signalling co-stimulates murine T cells and prevents induction of anergy in T-cell clones. Nature, 356, 607-609.
58. Hickman S. P., Yang J., Thomas R. M., Wells A. D. and Turka L. A. (2006): Defective activation of protein kinase C and Ras-ERK pathways limits IL-2 production and proliferation by CD4+CD25+ regulatory T cells. J. Immunol., 177, 2186-2194.
59. Hori S., Haury M., Lafaille J. J., Demengeot J. and Coutinho A. (2002): Peripheral expansion of thymus-derived regulatory cells in anti-myelin basic protein T cell receptor transgenic mice. Eur. J. Immunol., 32, 3729-3735.
60. Hori S., Nomura T. and Sakaguchi S. (2003): Control of regulatory T cell development by the transcription factor Foxp3. Science, 299,1057-1061.
61. Hori S., Takahashi T. and Sakaguchi S. (2003): Control of autoimmunity by naturally arising regulatory CD4+ T cells. Adv. Immunol., 81, 331-371.
62. Hsieh C. S., Liang Y., Tyznik A. J., Self S. G., Liggitt D. and Rudensky A. Y. (2004): Recognition of the peripheral self by naturally arising CD25+ CD4+ T cell receptors. Immunity, 21, 267-277.
63. Hsieh C. S., Zheng Y., Liang Y., Fontenot J. D. and Rudensky A. Y. (2006): An intersection between the self-reactive regulatory and nonregulatory T cell receptor repertoires. Nat. Immunol., 7, 401-410.
64. Huan J., Culbertson N., Spencer L., Bartholomew R., Burrows G. G., Chou Y. K., Bourdette D., Ziegler S. F., Offner H. and Vandenbark A. A. (2005): Decreased FOXP3 levels in multiple sclerosis patients. J. Neurosci. Res., 81, 45-52.
65. Huang C. T., Workman C. J., Flies D., Pan X., Marson A. L., Zhou G., Hipkiss E. L., Ravi S., Kowalski J., Levitsky H. I., Powell J. D., Pardoll D. M., Drake C. G. and Vignali D. A. (2004): Role of LAG-3 in regulatory T cells. Immunity, 21, 503-513.
66. Huber S., Schramm C., Lehr H. A., Mann A., Schmitt S., Becker C., Protschka M., Galle P. R., Neurath M. F. and Blessing M. (2004): Cutting edge: TGF-beta signaling is required for the in vivo expansion and immunosuppressive capacity of regulatory CD4+CD25+ T cells. J. Immunol., 173, 6526-6531.
67. Iellem A., Mariani M., Lang R., Recalde H., Panina-Bordignon P., Sinigaglia F. and D'Ambrosio D. (2001): Unique chemotactic response profile and specific expression of chemokine receptors CCR4 and CCR8 by CD4(+)CD25(+) regulatory T cells. J. Exp. Med., 194, 847-853.
68. Itoh M., Takahashi T., Sakaguchi N., Kuniyasu Y., Shimizu J., Otsuka F. and Sakaguchi S. (1999): Thymus and autoimmunity: production of CD25+CD4+ naturally anergic and suppressive T cells as a key function of the thymus in maintaining immunologic self-tolerance. J. Immunol., 162, 5317-5326.
69. Jonuleit H., Schmitt E., Stassen M., Tuettenberg A., Knop J. and Enk A. H. (2001): Identification and functional characterization of human CD4(+)CD25(+) T cells with regulatory properties isolated from peripheral blood. J. Exp. Med., 193, 1285-1294.
70. Jordan M. S., Boesteanu A., Reed A. J., Petrone A. L., Holenbeck A. E., Lerman M. A., Naji A. and Caton A. J. (2001): Thymic selection of CD4+CD25+ regulatory T cells induced by an agonist self-peptide. Nat. Immunol., 2, 301-306.
71. Kajiura F., Sun S., Nomura T., Izumi K., Ueno T., Bando Y., Kuroda N., Han H., Li Y., Matsushima A., Takahama Y., Sakaguchi S., Mitani T. and Matsumoto M. (2004): NF-kappa B-inducing kinase establishes self-tolerance in a thymic stroma-dependent manner. J. Immunol., 172, 2067-2075.
72. Karandikar N. J., Vanderlugt C. L., Walunas T. L., Miller S. D. and Bluestone J. A. (1996): CTLA-4: a negative regulator of autoimmune disease. J. Exp. Med., 184, 783-788.
73. Kashiwada M., Cattoretti G., McKeag L., Rouse T., Showalter B. M., Al-Alem U., Niki M., Pandolfi P. P., Field E. H. and Rothman P. B. (2006): Downstream of tyrosine kinases-1 and Src homology 2-containing inositol 5′-phosphatase are required for regulation of CD4+CD25+ T cell development. J. Immunol., 176, 3958-3965.
74. Khattri R., Cox T., Yasayko S. A. and Ramsdell F. (2003): An essential role for Scurfin in CD4+CD25+ T regulatory cells. Nat. Immunol., 4, 337-342.
75. Kingsley C. I., Karim M., Bushell A. R. and Wood K. J. (2002): CD25+CD4+ regulatory T cells prevent graft rejection: CTLA-4- and IL-10-dependent immunoregulation of alloresponses. J. Immunol., 168, 1080-1086.
76. Kishimoto H. and Sprent J. (1999): Several different cell surface molecules control negative selection of medullary thymocytes. J. Exp. Med., 190, 65-73.
77. Klein L., Khazaie K. and von Boehmer H. (2003): In vivo dynamics of antigen-specific regulatory T cells not predicted from behavior in vitro. Proc. Natl. Acad. Sci. USA, 100, 8886-8891.
78. Ko K., Yamazaki S., Nakamura K., Nishioka T., Hirota K., Yamaguchi T., Shimizu J., Nomura T., Chiba T. and Sakaguchi S. (2005): Treatment of advanced tumors with agonistic anti-GITR mAb and its effects on tumor-infiltrating Foxp3+CD25+CD4+ regulatory T cells. J. Exp. Med., 202, 885-891.
79. Kojima A., Tanaka-Kojima Y., Sakakura T. and Nishizuka Y. (1976): Spontaneous development of autoimmune thyroiditis in neonatally thymectomized mice. Lab. Invest., 34, 550-557.
80. Koonpaew S., Shen S., Flowers L. and Zhang W. (2006): LAT-mediated signaling in CD4+CD25+ regulatory T cell development. J. Exp. Med., 203, 119-129.
81. Kuhn R., Lohler J., Rennick D., Rajewsky K. and Muller W. (1993): Interleukin-10-deficient mice develop chronic enterocolitis. Cell, 75, 263-274.
82. Kullberg M. C., Ward J. M., Gorelick P. L., Caspar P., Hieny S., Cheever A., Jankovic D. and Sher A. (1998): Helicobacter hepaticus triggers colitis in specific-pathogenfree interleukin-10 (IL-10)-deficient mice through an IL-12- and gamma interferon-dependent mechanism. Infect. Immun., 66, 5157-5166.
83. Kuniyasu Y., Takahashi T., Itoh M., Shimizu J., Toda G. and Sakaguchi S. (2000): Naturally anergic and suppressive CD25(+)CD4(+) T cells as a functionally and phenotypically distinct immunoregulatory T cell subpopulation. Int. Immunol., 12, 1145-1155.
84. Leach D. R., Krummel M. F. and Allison J. P. (1996): Enhancement of antitumor immunity by CTLA-4 blockade. Science, 271, 1734-1736.
85. Lee M. K., Moore D. J., Jarrett B. P., Lian M. M., Deng S., Huang X., Markmann J. W., Chiaccio M., Barker C. F., Caton A. J. and Markmann J. F. (2004): Promotion of allograft survival by CD4+CD25+ regulatory T cells: evidence for in vivo inhibition of effector cell proliferation. J. Immunol. 172, 6539-6544.
86. Lehmann J., Huehn J., de la Rosa M., Maszyna F., Kretschmer U., Krenn V., Brunner M., Scheffold A. and Hamann A. (2002): Expression of the integrin alpha Ebeta 7 identifies unique subsets of CD25+ as well as CD25- regulatory T cells. Proc. Natl. Acad. Sci. USA, 99, 13031-13036.
87. Levings M. K., Sangregorio R. and Roncarolo M. G. (2001): Human cd25(+)cd4(+) t regulatory cells suppress naive and memory T cell proliferation and can be expanded in vitro without loss of function. J. Exp. Med., 193, 1295-1302.
88. Li L., Godfrey W. R., Porter S. B., Ge Y., June C. H., Blazar B. R. and Boussiotis V. A. (2005): CD4+CD25+ regulatory T-cell lines from human cord blood have functional and molecular properties of T-cell anergy. Blood, 106, 3068-3073.
89. Lim H. W., Hillsamer P., Banham A. H. and Kim C. H. (2005): Cutting edge: direct suppression of B cells by CD4+ CD25+ regulatory T cells. J. Immunol., 175, 4180-4183.
90. Lin X., O'Mahony A., Mu Y., Geleziunas R. and Greene W. C. (2000): Protein kinase C-theta participates in NF-kappaB activation induced by CD3-CD28 costimulation through selective activation of IkappaB kinase beta. Mol. Cell Biol., 20, 2933-2940.
91. Liston A., Lesage S., Wilson J., Peltonen L. and Goodnow C. C. (2003): Aire regulates negative selection of organ-specific T cells. Nat. Immunol., 4, 350-354.
92. Luhder F., Hoglund P., Allison J. P., Benoist C. and Mathis D. (1998): Cytotoxic T lymphocyte-associated antigen 4 (CTLA-4) regulates the unfolding of autoimmune diabetes. J. Exp. Med., 187, 427-432.
93. Malek T. R., Yu A., Vincek V., Scibelli P. and Kong L. (2002): CD4 regulatory T cells prevent lethal autoimmunity in IL-2Rbeta-deficient mice. Implications for the nonredundant function of IL-2. Immunity, 17,167-178.
94. Mamura M., Lee W., Sullivan T. J., Felici A., Sowers A. L., Allison J. P. and Letterio J. J. (2004): CD28 disruption exacerbates inflammation in Tgf-beta1-/- mice: in vivo suppression by CD4+CD25+ regulatory T cells independent of autocrine TGF-beta1. Blood, 103, 4594-4601.
95. Manicassamy S., Gupta S., Huang Z. and Sun Z. (2006): Protein kinase C-theta-mediated signals enhance CD4+ T cell survival by up-regulating Bcl-xL. J. Immunol., 176, 6709-6716.
96. Manicassamy S. and Sun Z. (2007): The critical role of protein kinase C-theta in Fas/Fas ligand-mediated apoptosis. J. Immunol., 178, 312-319.
97. Mantel P. Y., Ouaked N., Ruckert B., Karagiannidis C., Welz R., Blaser K. and Schmidt-Weber C. B. (2006): Molecular mechanisms underlying FOXP3 induction in human T cells. J. Immunol., 176, 3593-3602.
98. Marie J. C., Letterio J. J., Gavin M. and Rudensky A. Y. (2005): TGF-beta1 maintains suppressor function and Foxp3 expression in CD4+CD25+ regulatory T cells. J. Exp. Med., 201, 1061-1067.
99. Marski M., Kandula S., Turner J. R. and Abraham C. (2005): CD18 is required for optimal development and function of CD4+CD25+ T regulatory cells. J. Immunol., 175, 7889-7897.
100. McHugh R. S., Whitters M. J., Piccirillo C. A., Young D. A., Shevach E. M., Collins M. and Byrne M. C. (2002): CD4(+)CD25(+) immunoregulatory T cells: gene expression analysis reveals a functional role for the glucocorticoid- induced TNF receptor. Immunity, 16, 311-323.
101. Misra N., Bayry J., Lacroix-Desmazes S., Kazatchkine M. D. and Kaveri S. V. (2004): Cutting edge: human CD4+CD25+ T cells restrain the maturation and antigen-presenting function of dendritic cells. J. Immunol., 172, 4676-4680.
102. Miura Y., Thoburn C. J., Bright E. C., Phelps M. L., Shin T., Matsui E. C., Matsui W. H., Arai S., Fuchs E. J, Vogelsang G. B., Jones R. J. and Hess A. D. (2004): Association of Foxp3 regulatory gene expression with graft-versus-host disease. Blood, 104, 2187-2193.
103. Morrissey P. J., Charrier K., Braddy S., Liggitt D. and Watson J. D. (1993): CD4+ T cells that express high levels of CD45RB induce wasting disease when transferred into congenic severe combined immunodeficient mice. Disease development is prevented by cotransfer of purified CD4+ T cells. J. Exp. Med., 178, 237-244.
104. Mottet C., Uhlig H. H. and Powrie F. (2003): Cutting edge: cure of colitis by CD4+CD25+ regulatory T cells. J. Immunol., 170, 3939-3943.
105. Nakamura K., Kitani A., Fuss I., Pedersen A., Harada N., Nawata H. and Strober W. (2004): TGF-beta 1 plays an important role in the mechanism of CD4+CD25+ regulatory T cell activity in both humans and mice. J. Immunol., 172, 834-842.
106. Nakamura K., Kitani A. and Strober W. (2001): Cell contact-dependent immunosuppression by CD4(+)CD25(+) regulatory T cells is mediated by cell surface-bound transforming growth factor beta. J. Exp. Med., 194, 629-644.
107. Nishimura E., Sakihama T., Setoguchi R., Tanaka K. and Sakaguchi S. (2004): Induction of antigen-specific immunologic tolerance by in vivo and in vitro antigen-specific expansion of naturally arising Foxp3+CD25+CD4+ regulatory T cells. Int. Immunol., 16, 1189-1201.
108. Ono M., Shimizu J., Miyachi Y. and Sakaguchi S. (2006): Control of autoimmune myocarditis and multiorgan inflammation by glucocorticoid-induced TNF receptor family-related protein(high), Foxp3-expressing CD25+ and CD25- regulatory T cells. J. Immunol., 176, 4748-4756.
109. Ostroukhova M., Qi Z., Oriss T. B., Dixon-McCarthy B., Ray P. and Ray A. (2006): Treg-mediated immunosuppression involves activation of the Notch-HES1 axis by membrane-bound TGF-beta. J. Clin. Invest., 116, 996-1004.
110. Pacholczyk R., Ignatowicz H., Kraj P. and Ignatowicz L. (2006): Origin and T cell receptor diversity of Foxp3+CD4+CD25+ T cells. Immunity, 25, 249-259.
111. Pacholczyk R., Kern J., Singh N., Iwashima M., Kraj P. and Ignatowicz L. (2007): Nonself-antigens are the cognate specificities of Foxp3+ regulatory T cells. Immunity, 27, 493-504.
112. Papiernik M., de Moraes M. L., Pontoux C., Vasseur F. and Penit C. (1998): Regulatory CD4 T cells: expression of IL-2R alpha chain, resistance to clonal deletion and IL-2 dependency. Int. Immunol., 10, 371-378.
113. Peng Y., Laouar Y., Li M. O., Green E. A. and Flavell R. A. (2004): TGF-beta regulates in vivo expansion of Foxp3-expressing CD4+CD25+ regulatory T cells responsible for protection against diabetes. Proc. Natl. Acad. Sci. USA, 101, 4572-4577.
114. Perez V. L., Van Parijs L., Biuckians A., Zheng X. X., Strom T. B. and Abbas A. K. (1997): Induction of peripheral T cell tolerance in vivo requires CTLA-4 engagement. Immunity, 6, 411-417.
115. Perrin P. J., Maldonado J. H., Davis T. A., June C. H. and Racke M. K. (1996): CTLA-4 blockade enhances clinical disease and cytokine production during experimental allergic encephalomyelitis. J. Immunol., 157, 1333-1336.
116. Pfeifhofer C., Kofler K., Gruber T., Tabrizi N. G., Lutz C., Maly K., Leitges M. and Baier G. (2003): Protein kinase C theta affects Ca2+ mobilization and NFAT cell activation in primary mouse T cells. J. Exp. Med., 197, 1525-1535.
117. Piccirillo C. A., Letterio J. J., Thornton A. M., McHugh R. S., Mamura M., Mizuhara H. and Shevach E. M. (2002): CD4(+)CD25(+) regulatory T cells can mediate suppressor function in the absence of transforming growth factor beta1 production and responsiveness. J. Exp. Med. 196, 237-246.
118. Piccirillo C. A. and Shevach E. M. (2001): Cutting edge: control of CD8+ T cell activation by CD4+CD25+ immunoregulatory cells. J. Immunol., 167, 1137-1140.
119. Powell B. R., Buist N. R. and Stenzel P. (1982): An X-linked syndrome of diarrhea, polyendocrinopathy, and fatal infection in infancy. J. Pediatr., 100, 731-737.
120. Powrie F., Leach M. W., Mauze S., Caddle L. B. and Coffman R. L. (1993): Phenotypically distinct subsets of CD4+ T cells induce or protect from chronic intestinal inflammation in C. B-17 scid mice. Int. Immunol., 5, 1461-1471.
121. Powrie F. and Mason D. (1990): OX-22high CD4+ T cells induce wasting disease with multiple organ pathology: prevention by the OX-22low subset. J. Exp. Med., 172, 1701-1708.
122. Punt J. A., Havran W., Abe R., Sarin A. and Singer A. (1997): T cell receptor (TCR)-induced death of immature CD4+CD8+ thymocytes by two distinct mechanisms differing in their requirement for CD28 costimulation: implications for negative selection in the thymus. J. Exp. Med., 186, 1911-1922.
123. Read S., Malmstrom V. and Powrie F. (2000): Cytotoxic T lymphocyte-associated antigen 4 plays an essential role in the function of CD25(+)CD4(+) regulatory cells that control intestinal inflammation. J. Exp. Med., 192, 295-302.
124. Ribot J., Romagnoli P. and van Meerwijk J. P. (2006): Agonist ligands expressed by thymic epithelium enhance positive selection of regulatory T lymphocytes from precursors with a normally diverse TCR repertoire. J. Immunol., 177, 1101-1107.
125. Sakaguchi S., Fukuma K., Kuribayashi K. and Masuda T. (1985): Organ-specific autoimmune diseases induced in mice by elimination of T cell subset. I. Evidence for the active participation of T cells in natural self-tolerance; deficit of a T cell subset as a possible cause of autoimmune disease. J. Exp. Med., 161, 72-87.
126. Sakaguchi S., Sakaguchi N., Asano M., Itoh M. and Toda M. (1995): Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J. Immunol., 155, 1151-1164.
127. Sakaguchi S., Sakaguchi N., Shimizu J., Yamazaki S., Sakihama T., Itoh M., Kuniyasu Y., Nomura T., Toda M. and Takahashi T. (2001): Immunologic tolerance maintained by CD25+ CD4+ regulatory T cells: their common role in controlling autoimmunity, tumor immunity, and transplantation tolerance. Immunol. Rev., 182, 18-32.
128. Salomon B., Lenschow D. J., Rhee L., Ashourian N., Singh B., Sharpe A. and Bluestone J. A. (2000): B7/CD28 costimulation is essential for the homeostasis of the CD4+CD25+ immunoregulatory T cells that control autoimmune diabetes. Immunity, 12, 431-440.
129. Sarween N., Chodos A., Raykundalia C., Khan M., Abbas A. K. and Walker L. S. (2004): CD4+CD25+ cells controlling a pathogenic CD4 response inhibit cytokine differentiation, CXCR-3 expression, and tissue invasion. J. Immunol., 173, 2942-2951.
130. Schmidt-Supprian M., Tian J., Grant E. P., Pasparakis M., Maehr R., Ovaa H., Ploegh H. L., Coyle A. J. and Rajewsky K. (2004): Differential dependence of CD4+CD25+ regulatory and natural killer-like T cells on signals leading to NF-kappaB activation. Proc. Natl. Acad. Sci. USA, 101, 4566-4571.
131. Schneider H., Valk E., da Rocha Dias S., Wei B. and Rudd C. E. (2005): CTLA-4 up-regulation of lymphocyte function-associated antigen 1 adhesion and clustering as an alternate basis for coreceptor function. Proc. Natl. Acad. Sci. USA, 102, 12861-12866.
132. Schorle H., Holtschke T., Hunig T., Schimpl A. and Horak I. (1991): Development and function of T cells in mice rendered interleukin-2 deficient by gene targeting. Nature, 352, 621-624.
133. Seddon B. and Mason D. (1999): Peripheral autoantigen induces regulatory T cells that prevent autoimmunity. J. Exp. Med., 189, 877-882.
134. Seddon B. and Mason D. (1999): Regulatory T cells in the control of autoimmunity: the essential role of transforming growth factor beta and interleukin 4 in the prevention of autoimmune thyroiditis in rats by peripheral CD4(+)CD45RC(-) cells and CD4(+)CD8(-) thymocytes. J. Exp. Med., 189, 279-288.
135. Seddon B. and Zamoyska R. (2002): TCR and IL-7 receptor signals can operate independently or synergize to promote lymphopenia-induced expansion of naive T cells. J. Immunol., 169, 3752-3759.
136. Sellon R. K., Tonkonogy S., Schultz M., Dieleman L. A., Grenther W., Balish E., Rennick D. M. and Sartor R. B. (1998): Resident enteric bacteria are necessary for development of spontaneous colitis and immune system activation in interleukin-10-deficient mice. Infect. Immun., 66, 5224-5231.
137. Setoguchi R., Hori S., Takahashi T. and Sakaguchi S. (2005): Homeostatic maintenance of natural Foxp3(+) CD25(+) CD4(+) regulatory T cells by interleukin (IL)-2 and induction of autoimmune disease by IL-2 neutralization. J. Exp. Med., 201, 723-735.
138. Shen S., Ding Y., Tadokoro C. E., Olivares-Villagomez D., Camps-Ramirez M., Curotto de Lafaille M. A. and Lafaille J. J. (2005): Control of homeostatic proliferation by regulatory T cells. J. Clin. Invest., 115, 3517-3526.
139. Shimizu J., Yamazaki S., Takahashi T., Ishida Y. and Sakaguchi S. (2002): Stimulation of CD25(+)CD4(+) regulatory T cells through GITR breaks immunological self-tolerance. Nat. Immunol., 3, 135-142.
140. Soper D. M., Kasprowicz D. J. and Ziegler S. F. (2007): IL-2Rbeta links IL-2R signaling with Foxp3 expression. Eur. J. Immunol., 37, 1817-1826.
141. Stephens G. L. and Ignatowicz L. (2003): Decreasing the threshold for thymocyte activation biases CD4+ T cells toward a regulatory (CD4+CD25+) lineage. Eur. J. Immunol., 33, 1282-1291.
142. Sun Z., Arendt C. W., Ellmeier W., Schaeffer E. M., Sunshine M. J., Gandhi L., Annes J., Petrzilka D., Kupfer A., Schwartzberg P. L. and Littman D. R. (2000): PKC--theta is required for TCR-induced NF-kappaB activation in mature but not immature T lymphocytes. Nature, 404, 402-407.
143. Suri-Payer E. and Cantor H. (2001): Differential cytokine requirements for regulation of autoimmune gastritis and colitis by CD4(+)CD25(+) T cells. J. Autoimmun., 16, 115-123.
144. Suto A., Nakajima H., Ikeda K., Kubo S., Nakayama T., Taniguchi M., Saito Y. and Iwamoto I. (2002): CD4(+)CD25(+) T-cell development is regulated by at least 2 distinct mechanisms. Blood, 99, 555-560.
145. Suvas S., Kumaraguru U., Pack C. D., Lee S. and Rouse B. T. (2003): CD4+CD25+ T cells regulate virus-specific primary and memory CD8+ T cell responses. J. Exp. Med., 198, 889-901.
146. Szanya V., Ermann J., Taylor C., Holness C. and Fathman C. G. (2002): The subpopulation of CD4+CD25+ splenocytes that delays adoptive transfer of diabetes expresses L-selectin and high levels of CCR7. J. Immunol., 169, 2461-2465.
147. Tai X., Cowan M., Feigenbaum L. and Singer A. (2005): CD28 costimulation of developing thymocytes induces Foxp3 expression and regulatory T cell differentiation independently of interleukin 2. Nat. Immunol., 6, 152-162.
148. Takahashi T., Kuniyasu Y., Toda M., Sakaguchi N., Itoh M., Iwata M., Shimizu J. and Sakaguchi S. (1998): Immunologic self-tolerance maintained by CD25+CD4+ naturally anergic and suppressive T cells: induction of autoimmune disease by breaking their anergic/suppressive state. Int. Immunol., 10, 1969-1980.
149. Takahashi T., Tagami T., Yamazaki S., Uede T., Shimizu J., Sakaguchi N., Mak T. W. and Sakaguchi S. (2000): Immunologic self-tolerance maintained by CD25(+)CD4(+) regulatory T cells constitutively expressing cytotoxic T lymphocyte-associated antigen 4. J. Exp. Med., 192, 303-310.
150. Tang Q., Adams J. Y., Tooley A. J., Bi M., Fife B. T., Serra P., Santamaria P., Locksley R. M., Krummel M. F. and Bluestone J. A. (2006): Visualizing regulatory T cell control of autoimmune responses in nonobese diabetic mice. Nat. Immunol., 7, 83-92.
151. Tang Q., Boden E. K., Henriksen K. J., Bour-Jordan H., Bi M. and Bluestone J. A. (2004): Distinct roles of CTLA-4 and TGF-beta in CD4+CD25+ regulatory T cell function. Eur. J. Immunol., 34, 2996-3005.
152. Tang Q., Henriksen K. J., Boden E. K., Tooley A. J., Ye J., Subudhi S. K., Zheng X. X., Strom T. B. and Bluestone J. A. (2003): Cutting edge: CD28 controls peripheral homeostasis of CD4+CD25+ regulatory T cells. J. Immunol., 171, 3348-3352.
153. Taylor S. R., Alexander D. R., Cooper J. C., Higgins C. F. and Elliott J. I. (2007): Regulatory T cells are resistant to apoptosis via TCR but not P2X7. J. Immunol., 178, 3474-3482.
154. Thornton A. M., Donovan E. E., Piccirillo C. A. and Shevach E. M. (2004): Cutting edge: IL-2 is critically required for the in vitro activation of CD4+CD25+ T cell suppressor function. J. Immunol., 172, 6519-6523.
155. Thornton A. M., Piccirillo C. A. and Shevach E. M. (2004): Activation requirements for the induction of CD4+CD25+ T cell suppressor function. Eur. J. Immunol., 34, 366-376.
156. Thornton A. M. and Shevach E. M. (1998): CD4+CD25+ immunoregulatory T cells suppress polyclonal T cell activation in vitro by inhibiting interleukin 2 production. J. Exp. Med., 188, 287-296.
157. Thornton A. M. and Shevach E. M. (2000): Suppressor effector function of CD4+CD25+ immunoregulatory T cells is antigen nonspecific. J. Immunol., 164, 183-190.
158. Tivol E. A., Borriello F., Schweitzer A. N., Lynch W. P., Bluestone J. A. and Sharpe A. H. (1995): Loss of CTLA-4 leads to massive lymphoproliferation and fatal multiorgan tissue destruction, revealing a critical negative regulatory role of CTLA-4. Immunity, 3, 541-547.
159. Tung K. S., Smith S., Teuscher C., Cook C. and Anderson R. E. (1987): Murine autoimmune oophoritis, epididymoorchitis, and gastritis induced by day 3 thymectomy. Am. J. Pathol., 126, 293-302.
160. Uhlig H. H., Coombes J., Mottet C., Izcue A., Thompson C., Fanger A., Tannapfel A., Fontenot J. D., Ramsdell F. and Powrie F. (2006): Characterization of Foxp3+CD4+ CD25+ and IL-10-secreting CD4+CD25+ T cells during cure of colitis. J. Immunol., 177, 5852-5860.
161. Uraushihara K., Kanai T., Ko K., Totsuka T., Makita S., Iiyama R., Nakamura T. and Watanabe M. (2003): Regulation of murine inflammatory bowel disease by CD25+ and CD25- CD4+ glucocorticoid-induced TNF receptor family-related gene+ regulatory T cells. J. Immunol., 171, 708-716.
162. Van Parijs L., Refaeli Y., Lord J. D., Nelson B. H., Abbas A. K. and Baltimore D. (1999): Uncoupling IL-2 signals that regulate T cell proliferation, survival, and Fas-mediated activation-induced cell death. Immunity, 11, 281-288.
163. van Santen H. M., Benoist C. and Mathis D. (2004): Number of T reg cells that differentiate does not increase upon encounter of agonist ligand on thymic epithelial cells. J. Exp. Med., 200, 1221-1230.
164. Viglietta V., Baecher-Allan C., Weiner H. L. and Hafler D. A. (2004): Loss of functional suppression by CD4+CD25+ regulatory T cells in patients with multiple sclerosis. J. Exp. Med., 199, 971-979.
165. Viret C., Barlow A. K. and Janeway C. A. Jr. (1999): On the intrathymic intercellular transfer of self-determinants. Immunol. Today, 20, 8-10.
166. Visan I., Yuan J. S., Tan J. B., Cretegny K. and Guidos C. J. (2006): Regulation of intrathymic T-cell development by Lunatic Fringe- Notch1 interactions. Immunol. Rev., 209, 76-94.
167. Walker L. S., Chodos A., Eggena M., Dooms H. and Abbas A. K. (2003): Antigen-dependent proliferation of CD4+ CD25+ regulatory T cells in vivo. J. Exp. Med., 198, 249-258.
168. Walker M. R., Kasprowicz D. J., Gersuk V. H., Benard A., Van Landeghen M., Buckner J. H. and Ziegler S. F. (2003): Induction of FoxP3 and acquisition of T regulatory activity by stimulated human CD4+CD25- T cells. J. Clin. Invest., 112, 1437-1443.
169. Wan Y. Y. and Flavell R. A. (2005): Identifying Foxp3-expressing suppressor T cells with a bicistronic reporter. Proc. Natl. Acad. Sci. USA, 102, 5126-5131.
170. Wan Y. Y. and Flavell R. A. (2007): Regulatory T-cell functions are subverted and converted owing to attenuated Foxp3 expression. Nature, 445, 766-770.
171. Watanabe N., Wang Y. H., Lee H. K., Ito T., Cao W. and Liu Y. J. (2005): Hassall's corpuscles instruct dendritic cells to induce CD4+CD25+ regulatory T cells in human thymus. Nature, 436, 1181-1185.
172. Waterhouse P., Penninger J. M., Timms E., Wakeham A., Shahinian A., Lee K. P., Thompson C. B., Griesser H. and Mak T. W. (1995): Lymphoproliferative disorders with early lethality in mice deficient in Ctla-4. Science, 270, 985-988.
173. Willerford D. M., Chen J., Ferry J. A., Davidson L., Ma A. and Alt F. W. (1995): Interleukin-2 receptor alpha chain regulates the size and content of the peripheral lymphoid compartment. Immunity, 3, 521-530.
174. Wu Y., Borde M., Heissmeyer V., Feuerer M., Lapan A. D., Stroud J. C., Bates D. L., Guo L.,. Han A, Ziegler S. F., Mathis D., Benoist C., Chen L. and Rao A. (2006): FOXP3 controls regulatory T cell function through cooperation with NFAT. Cell, 126, 375-387.
175. Yagi H., Nomura T., Nakamura K., Yamazaki S., Kitawaki T., Hori S., Maeda M., Onodera M., Uchiyama T., Fujii S. and Sakaguchi S. (2004): Crucial role of FOXP3 in the development and function of human CD25+CD4+ regulatory T cells. Int. Immunol., 16, 1643-1656.
176. Yamagiwa S., Gray J. D., Hashimoto S. and Horwitz D. A. (2001): A role for TGF-beta in the generation and expansion of CD4+CD25+ regulatory T cells from human peripheral blood. J. Immunol., 166, 7282-7289.
177. Yamazaki S., Iyoda T., Tarbell K., Olson K., Velinzon K., Inaba K. and Steinman R. M. (2003): Direct expansion of functional CD25+ CD4+ regulatory T cells by antigen-processing dendritic cells. J. Exp. Med., 198, 235-247.
178. Yao Z., Kanno Y., Kerenyi M., Stephens G., Durant L., Watford W. T., Laurence A., Robinson G. W., Shevach E. M., Moriggl R., Hennighausen L., Wu C. and O'Shea J. J. (2007): Nonredundant roles for Stat5a/b in directly regulating Foxp3. Blood, 109, 4368-4375.
179. Zhang H., Chua K. S., Guimond M., Kapoor V., Brown M. V., Fleisher T. A., Long L. M., Bernstein D., Hill B. J., Douek D. C., Berzofsky J. A., Carter C. S., Read E. J., Helman L. J. and Mackall C. L. (2005): Lymphopenia and interleukin-2 therapy alter homeostasis of CD4+CD25+ regulatory T cells. Nat. Med., 11, 1238-1243.
180. Zhang W., Sommers C. L., Burshtyn D. N., Stebbins C. C., DeJarnette J. B., Trible R. P., Grinberg A., Tsay H. C., Jacobs H. M., Kessler C. M., Long E. O., Love P. E. and Samelson L. E. (1999): Essential role of LAT in T cell development. Immunity, 10, 323-332.
181. Zhao D. M., Thornton A. M., DiPaolo R. J. and Shevach E. M. (2006): Activated CD4+CD25+ T cells selectively kill B lymphocytes. Blood, 107, 3925-3932.